Li Y, Zheng X, Tu D, Ingle JN, et al. Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R. Breast Cancer Res Treat 2021 Nov 26. pii: 10.1007/s10549-021-06448.
PMID: 34825307